Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Lipid Res ; 59(12): 2413-2420, 2018 12.
Article in English | MEDLINE | ID: mdl-30348640

ABSTRACT

Neu-Laxova syndrome (NLS) is a very rare autosomal recessive congenital disorder characterized by disturbed development of the central nervous system and the skin and caused by mutations in any of the three genes involved in de novo l-serine biosynthesis: PHGDH, PSAT1, and PSPH l-Serine is essential for the biosynthesis of phosphatidylserine and sphingolipids. The extracellular lipid of the stratum corneum, of which sphingolipid constitutes a significant part, plays a primary role in skin barrier function. Here, we describe a Japanese NLS pedigree with a previously unreported nonsense mutation in PHGDH and a unique inversion of chromosome 1. In addition, the levels of 11 major ceramide classes in the tape-stripped stratum corneum of the NLS patient's skin were assessed by LC/MS. Notably, lower amounts of ceramides of all classes were found in the patient's stratum corneum than in those of controls. This is the first report to demonstrate the reduction of ceramides in the stratum corneum of an NLS patient due to PHGDH mutations. The clinical findings and a detailed analysis of ceramides from the stratum corneum in the family extend the spectrum of clinical anomalies and give us a clue to the pathomechanisms of ichthyosis in NLS patients with phosphoglycerate dehydrogenase deficiency.


Subject(s)
Abnormalities, Multiple/metabolism , Brain Diseases/metabolism , Carbohydrate Metabolism, Inborn Errors/metabolism , Ceramides/metabolism , Fetal Growth Retardation/metabolism , Ichthyosis/metabolism , Limb Deformities, Congenital/metabolism , Microcephaly/metabolism , Phosphoglycerate Dehydrogenase/deficiency , Phosphoglycerate Dehydrogenase/metabolism , Psychomotor Disorders/metabolism , Seizures/metabolism , Adult , Amino Acids/metabolism , Female , Gestational Age , Humans , Immunohistochemistry , Infant, Newborn , Male , Pregnancy , Sphingolipids/metabolism , Exome Sequencing , Young Adult
5.
Med Mycol J ; 55(1): E21-7, 2014.
Article in English | MEDLINE | ID: mdl-24682094

ABSTRACT

A 28-year-old man undergoing treatment for hemophagocytic syndrome developed Paecilomyces lilacinus infection in skin ulcers on the face and in the tracheotomy stoma. While his bone marrow was suppressed by chemotherapy with dexamethasone, cyclosporin and etoposide for hemophagocytic syndrome, dental infection led to subacute necrotizing fasciitis caused by Pseudomonas aeruginosa on the right side of the face, resulting in a large area of soft tissue defects. Etoposide was discontinued, and prophylactic treatment with itraconazole was initiated. The ulcers resulting from necrotizing fasciitis were treated conservatively using trafermin and alprostadil alfadex ointment 0.003 %, and near-complete re-epithelialization occurred, except on the right lower eyelid, right buccal mucosa and perioral area. However, 6 weeks later, pustules/crusts started to form and break down repeatedly, leading to expansion of tissue defects on the face. Direct microscopic examination revealed fungal elements, and fungal culture identified Paecilomyces lilacinus suspicious twice some other day. Based on DNA extraction from the isolated fungus, this fungal strain was identified as Paecilomyces lilacinus. Cyclosporin and itraconazole were discontinued, and treatment with liposomal amphotericin B and a tapering dose of steroids was initiated. Cure was achieved in approximately 2.5 months after treatment initiation, and no relapse has been observed. The most important factor that ultimately contributed to the resolution of fungal infection might have been release of immunosuppression by discontinuing cyclosporin and tapering steroids.


Subject(s)
Face , Fasciitis, Necrotizing/microbiology , Mycoses/drug therapy , Mycoses/etiology , Paecilomyces , Skin Ulcer/drug therapy , Skin Ulcer/microbiology , Surgical Stomas , Tracheotomy , Adult , Amphotericin B/administration & dosage , Antifungal Agents/administration & dosage , Cyclosporine/adverse effects , Dexamethasone/adverse effects , Fasciitis, Necrotizing/etiology , Humans , Immune Tolerance/drug effects , Lymphohistiocytosis, Hemophagocytic/complications , Lymphohistiocytosis, Hemophagocytic/drug therapy , Male , Pseudomonas Infections , Pseudomonas aeruginosa , Skin Ulcer/etiology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...